Vildagliptin Metformin NOBEL 50 mg/500 mg

Vildagliptin Metformin NOBEL 50 mg/500 mg is a medicine authorised by Swissmedic under authorisation number 69069. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 July 2024 and the authorisation is limited until 14 July 2029. ATC code A10BD08 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 69069
  • ATC A10BD08
  • Synthetic medicines
Authorisation data
Authorisation number69069
NameVildagliptin Metformin NOBEL 50 mg/500 mg
Full nameVildagliptin Metformin NOBEL 50 mg/500 mg, Filmtabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BD08
First authorisation15 July 2024
Authorisation validity14 July 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Vildagliptin Metformin NOBEL 50 mg/500 mg, FilmtablettenB15 July 2024
2Vildagliptin Metformin NOBEL 50 mg/850 mg, FilmtablettenB15 July 2024
3Vildagliptin Metformin NOBEL 50 mg/1000 mg, FilmtablettenB15 July 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
160Tablette(n)A10BD0807.06.2.B
2180Tablette(n)A10BD0807.06.2.B
360Tablette(n)A10BD0807.06.2.B
4180Tablette(n)A10BD0807.06.2.B
560Tablette(n)A10BD0807.06.2.B
6180Tablette(n)A10BD0807.06.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Vildagliptin Metformin NOBEL 50 mg/500 mg authorised in Switzerland?

Yes. Vildagliptin Metformin NOBEL 50 mg/500 mg is authorised by Swissmedic under authorisation number 69069, data as of 01 September 2026. The authorisation is limited until 14 July 2029.

Which dispensing category does Vildagliptin Metformin NOBEL 50 mg/500 mg have?

Vildagliptin Metformin NOBEL 50 mg/500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Vildagliptin Metformin NOBEL 50 mg/500 mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com